Flu Vaccine Availability in France: Additional Doses Released to Address Shortages (December 8, 2025)
Table of Contents
Teh French Directorate-General for Health (DGS) is releasing an additional 200,000 doses of the Vaxigrip flu vaccine, starting the week of December 8, 2025, to address reported tensions in vaccine supply and ensure continued access for at-risk populations. https://www.santé.gouv.fr/ (This is the official website of the French Ministry of Health, and while a direct link to this specific announcement wasn’t available, it’s the authoritative source for this facts). This action comes as over 10.3 million people in France have already received a flu vaccination this season, demonstrating strong public health engagement.
Current Vaccine Availability
As of december 8, 2025, the DGS has categorized available and in-demand flu vaccines as follows:
* Available:
* Flucelvax: Suitable for adults and children aged 2 years and older.
* Efluelda: Recommended for individuals aged 65 years and over.
* Fluad: Also recommended for individuals aged 65 years and over.
* In High Demand (Potential Shortages):
* Vaxigrip: Approved for use in adults and children from 6 months of age.
* Influvac: Approved for use in adults and children from 6 months of age.
Strategic Buffer Release of Vaxigrip
The release of the additional 200,000 Vaxigrip doses is a proactive measure to prevent disruptions in the vaccination campaign, particularly for vulnerable individuals who have not yet been vaccinated. Wholesalers-distributors have been instructed to place orders promptly.
The laboratory distributing the vaccine will adhere to the following delivery timelines:
* Mainland France (to dispatchers and hospitals): A maximum of 72 hours from order receipt.
* Overseas Territories: Up to 15 calendar days from order receipt.
It’s vital to note that wholesalers, hospitals, and pharmacies are responsible for covering the costs of vaccine acquisition and associated expenses.
Why is Flu Vaccination important?
Annual flu vaccination is a crucial public health strategy to reduce the spread of influenza and protect individuals from severe illness, hospitalization, and complications. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)) (World Health Organization – Influenza (seasonal)). Certain groups are at higher risk of complications from the flu, including:
* Older adults (65 years and older)
* Young children (under 5 years old)
* Pregnant women
* Individuals with chronic medical conditions (such as asthma, diabetes, or heart disease)
Primary Topic: flu Vaccine Availability in France
Primary Keyword: Flu Vaccine France
Secondary Keywords: Vaxigrip, Influvac, Flu Vaccination, French Health Ministry, DGS, Flu Season, Vaccine Shortage, Flucelvax, Efluelda, Fluad.